FAM217A

gene
On this page

Also known as MGC43581

Summary

FAM217A (family with sequence similarity 217 member A, HGNC:21362) is a protein-coding gene on chromosome 6p25.2, encoding Protein FAM217A (Q8IXS0).

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 81 total
  • MANE Select transcript: NM_173563

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21362
Approved symbolFAM217A
Namefamily with sequence similarity 217 member A
Location6p25.2
Locus typegene with protein product
StatusApproved
AliasesMGC43581
Ensembl geneENSG00000145975
Ensembl biotypeprotein_coding
Entrez222826

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 4 protein_coding, 4 protein_coding_CDS_not_defined

ENST00000274673, ENST00000380188, ENST00000463904, ENST00000469157, ENST00000478714, ENST00000492651, ENST00000498677, ENST00000639338

RefSeq mRNA: 1 — MANE Select: NM_173563 NM_173563

CCDS: CCDS4489

Canonical transcript exons

ENST00000274673 — 7 exons

ExonStartEnd
ENSE0000193654040683674069920
ENSE0000348176940734334073507
ENSE0000349890740745774074661
ENSE0000351343840773554077448
ENSE0000355773040744434074456
ENSE0000357544940732754073342
ENSE0000389524240788524079137

Expression profiles

Bgee: expression breadth ubiquitous, 163 present calls, max score 99.37.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0107 / max 8.5706, expressed in 4 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
715080.01074

Top tissues by expression

251 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001999.37gold quality
right testisUBERON:000453486.77gold quality
left testisUBERON:000453386.59gold quality
testisUBERON:000047384.09gold quality
buccal mucosa cellCL:000233683.91gold quality
calcaneal tendonUBERON:000370181.33gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047381.10gold quality
rectumUBERON:000105278.22gold quality
adrenal tissueUBERON:001830374.87gold quality
mucosa of stomachUBERON:000119973.39gold quality
body of pancreasUBERON:000115072.91gold quality
olfactory segment of nasal mucosaUBERON:000538672.77gold quality
tibialis anteriorUBERON:000138571.89silver quality
left adrenal gland cortexUBERON:003582571.15gold quality
monocyteCL:000057670.80gold quality
pancreatic ductal cellCL:000207970.70silver quality
right ovaryUBERON:000211870.65gold quality
body of stomachUBERON:000116170.28gold quality
skin of legUBERON:000151170.25gold quality
left adrenal glandUBERON:000123470.24gold quality
smooth muscle tissueUBERON:000113570.20gold quality
body of uterusUBERON:000985370.17gold quality
right adrenal gland cortexUBERON:003582770.03gold quality
minor salivary glandUBERON:000183069.91gold quality
right lungUBERON:000216769.58gold quality
left ovaryUBERON:000211968.89gold quality
adrenal cortexUBERON:000123568.78gold quality
corpus callosumUBERON:000233668.77gold quality
small intestine Peyer’s patchUBERON:000345468.73gold quality
transverse colonUBERON:000115768.55gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.88

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

32 targeting FAM217A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3134100.0066.43777
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-453499.9966.581907
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-6793-5P99.9765.95758
HSA-MIR-808299.9567.271170
HSA-MIR-23A-3P99.9574.243163
HSA-MIR-23B-3P99.9574.243163
HSA-MIR-23C99.9573.923192
HSA-MIR-10395-5P99.8667.35676
HSA-MIR-442099.8270.081624
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-6505-5P99.7369.251595
HSA-MIR-472999.6972.184233
HSA-MIR-314799.5266.34388
HSA-MIR-127599.4767.902749
HSA-MIR-6839-3P99.3968.861301
HSA-MIR-103A-2-5P99.3967.721577
HSA-MIR-6815-3P99.1368.981530
HSA-MIR-470599.1069.101091
HSA-MIR-629-5P98.7868.721032
HSA-MIR-6512-5P98.7669.291195
HSA-MIR-5585-3P98.2567.41941
HSA-MIR-124-5P98.1167.651095
HSA-MIR-4665-5P97.9167.691536

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriofam217baENSDARG00000088505
danio_reriofam217bbENSDARG00000091799
mus_musculusFam217aENSMUSG00000021414
rattus_norvegicusFam217aENSRNOG00000016672

Paralogs (1): FAM217B (ENSG00000196227)

Protein

Protein identifiers

Protein FAM217AQ8IXS0 (reviewed: Q8IXS0)

All UniProt accessions (4): A0A1W2PRP4, C9J5H0, C9J6U0, Q8IXS0

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the FAM217 family.

RefSeq proteins (1): NP_775834* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029266FAM217Family

Pfam: PF15344

UniProt features (6 total): sequence variant 5, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IXS0-F150.260.03

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 30 (showing top): DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_DN, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, chr6p25, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, SFMBT1_TARGET_GENES, MIR548F_5P, MIR548AJ_5P_MIR548G_5P_MIR548X_5P, MIR181B_2_3P_MIR181B_3P, MIR4420, MIR6505_5P, MIR4534

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

234 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
FAM217AOR6M1Q8NGM8581
FAM217AOR8H3Q8N146571
FAM217ARSPH10B2B2RC85543
FAM217AMROH9Q5TGP6512
FAM217AOR9G1Q8NH87507
FAM217ARSPH10BP0C881505
FAM217ACCDC81Q6ZN84479
FAM217ATMPRSS12Q86WS5478
FAM217AMFSD6LQ8IWD5478
FAM217AKRTCAP3Q53RY4435
FAM217AESPNLQ6ZVH7431
FAM217APCDHGA6Q9Y5G7419
FAM217AGPR62Q9BZJ7418
FAM217ASIAH3Q8IW03396
FAM217ASPACA1Q9HBV2370
FAM217ALCE3AQ5TA76370

IntAct

6 interactions, top by confidence:

ABTypeScore
FAM217ATEX11psi-mi:“MI:0915”(physical association)0.560
FAM217ACLNKpsi-mi:“MI:0915”(physical association)0.490
FAM217ATEX11psi-mi:“MI:0915”(physical association)0.000

BioGRID (5): FAM217A (Two-hybrid), FAM217A (Two-hybrid), FAM217A (Affinity Capture-MS), TET3 (Cross-Linking-MS (XL-MS)), FAM217A (Affinity Capture-RNA)

ESM2 similar proteins: A0A087WXM9, A0A2K1JJ00, A0JM83, A4IGL8, E1BC15, E9Q5F9, O14513, O35923, O60673, O88491, P46013, P97929, Q14B71, Q28DZ0, Q29RT4, Q3MHH3, Q3TNU4, Q3ZBP0, Q4QY64, Q4V7J0, Q5DTT3, Q5E9A0, Q5F2C3, Q5RD08, Q5VWN6, Q5VYV7, Q61493, Q69YH5, Q6NS59, Q703I1, Q80U59, Q86XD8, Q8IXS0, Q8IYL3, Q8L7I1, Q8N7Z5, Q8NFU7, Q8TEP8, Q92628, Q96BU1

Diamond homologs: Q5XHY8, Q8IXS0, Q9D9W6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign13
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2987 predictions. Top by Δscore:

VariantEffectΔscore
6:4049729:TA:Tacceptor_loss1.0000
6:4049730:A:AGacceptor_gain1.0000
6:4049731:G:GAacceptor_gain1.0000
6:4049731:GGT:Gacceptor_gain1.0000
6:4049731:GGTGT:Gacceptor_gain1.0000
6:4049880:G:GGdonor_gain1.0000
6:4051951:TTTTA:Tacceptor_loss1.0000
6:4051952:TTTA:Tacceptor_loss1.0000
6:4051954:TA:Tacceptor_loss1.0000
6:4051955:A:AGacceptor_gain1.0000
6:4051956:G:Aacceptor_loss1.0000
6:4051956:G:GGacceptor_gain1.0000
6:4052090:CTCAG:Cdonor_loss1.0000
6:4052094:GGTAC:Gdonor_loss1.0000
6:4052704:A:AGacceptor_gain1.0000
6:4052705:A:Gacceptor_gain1.0000
6:4052715:A:AGacceptor_gain1.0000
6:4052716:A:Gacceptor_gain1.0000
6:4052716:AAAG:Aacceptor_loss1.0000
6:4052717:A:AGacceptor_gain1.0000
6:4052717:AAGC:Aacceptor_loss1.0000
6:4052718:A:Gacceptor_gain1.0000
6:4052718:AGCAT:Aacceptor_gain1.0000
6:4052719:G:GAacceptor_gain1.0000
6:4052719:GC:Gacceptor_gain1.0000
6:4052719:GCAT:Gacceptor_gain1.0000
6:4052719:GCATG:Gacceptor_gain1.0000
6:4052874:G:GGdonor_gain1.0000
6:4056436:G:GGdonor_gain1.0000
6:4057185:AAGG:Adonor_loss1.0000

AlphaMissense

3365 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:4069339:C:GR295P0.987
6:4069354:A:GL290S0.984
6:4069345:A:GL293P0.983
6:4069468:A:GL252P0.977
6:4069468:A:CL252R0.974
6:4069357:C:GR289P0.973
6:4069341:T:AE294D0.972
6:4069341:T:GE294D0.972
6:4069342:T:AE294V0.972
6:4069468:A:TL252H0.971
6:4069429:G:TA265D0.969
6:4069351:A:GL291P0.964
6:4069441:A:GL261S0.961
6:4069481:A:CY248D0.953
6:4069409:A:GW272R0.952
6:4069409:A:TW272R0.952
6:4069332:T:AQ297H0.951
6:4069332:T:GQ297H0.951
6:4069471:A:GF251S0.950
6:4069358:G:TR289S0.939
6:4069333:T:GQ297P0.934
6:4069366:A:GL286S0.934
6:4069342:T:GE294A0.933
6:4069430:C:GA265P0.932
6:4069330:T:GH298P0.929
6:4069546:A:GL226S0.914
6:4069485:A:CF246L0.913
6:4069485:A:TF246L0.913
6:4069487:A:GF246L0.913
6:4069470:A:CF251L0.911

dbSNP variants (sampled 300 via entrez): RS1000085707 (6:4078013 T>C), RS1000210612 (6:4071773 T>C), RS1000329092 (6:4075218 C>T), RS1000428451 (6:4084728 T>C), RS1000663698 (6:4073696 C>A), RS1000875163 (6:4080198 C>T), RS1001068386 (6:4086779 C>G), RS1001090741 (6:4079357 C>A,G,T), RS1001245059 (6:4079952 G>T), RS1001297939 (6:4076411 G>A), RS1001379681 (6:4085891 C>T), RS1001699288 (6:4088906 G>A), RS1001733382 (6:4089108 A>G), RS1001909844 (6:4082924 C>A,G,T), RS1002034501 (6:4087740 G>A,T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003542_140Night sleep phenotypes9.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
FR900359increases phosphorylation1
hydroxyhydroquinoneincreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.